ConductScience.org, home

Paper40189720

The potential of miR-29 in modulating tumor angiogenesis: a comprehensive review.

Zhou RT and 4 others. Discov Oncol, 2025. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. The potential of miR-29 in modulating tumor angiogenesis: a comprehensive review. Papers, record 40189720. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40189720

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The potential of miR-29 in modulating tumor angiogenesis: a comprehensive review.
PubMed
Journal
Discov Oncol
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
1.36, provisional
iCite
Revised in PubMed
2025-04-09
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhou RTRui-Ting
2Luo XJXiao-Jie
3Zhang XXXiao-Xin-Ran
4Wu JFJiang-Fenghttps://orcid.org/0000-0002-4717-0141
5Ni YRYi-Ranhttps://orcid.org/0000-0002-4298-3231

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
81670555National Natural Science Foundation of ChinaPubMed
2060204State Key Laboratory Special FundPubMed
2022KZL2-07The Opening Foundation of Hubei Key Laboratory of Tumor Microenvironment and ImmunotherapyPubMed

Source PubMed

Download CSV of grants

References115

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127356624Ablation of MCL1 expression by virally induced microRNA-29 reverses chemoresistance in human osteosarcomas.Sci Rep2016https://conductscience.org/library/papers/27356624PubMed
231382461Role of MYC-miR-29-B7-H3 in Medulloblastoma Growth and Angiogenesis.J Clin Med2019https://conductscience.org/library/papers/31382461PubMed
323113351The microRNA-29 plays a central role in osteosarcoma pathogenesis and progression.Mol Biol (Mosk)2012https://conductscience.org/library/papers/23113351PubMed
428633655Inhibition of MMP-2 and MMP-9 decreases cellular migration, and angiogenesis in in vitro models of retinoblastoma.BMC Cancer2017https://conductscience.org/library/papers/28633655PubMed
531205560Cytochalasin H Inhibits Angiogenesis via the Suppression of HIF-1α Protein Accumulation and VEGF Expression through PI3K/AKT/P70S6K and ERK1/2 Signaling Pathways in Non-Small Cell Lung Cancer Cells.J Cancer2019https://conductscience.org/library/papers/31205560PubMed
618559520Tissue inhibitor of metalloproteinase 3 suppresses tumor angiogenesis in matrix metalloproteinase 2-down-regulated lung cancer.Cancer Res2008https://conductscience.org/library/papers/18559520PubMed
727826619Antiangiogenic cancer treatment: The great discovery and greater complexity (Review).Int J Oncol2016https://conductscience.org/library/papers/27826619PubMed
828345453Tumor suppressor miR-29c regulates radioresistance in lung cancer cells.Tumour Biol2017https://conductscience.org/library/papers/28345453PubMed
911586466Extracellular matrix degradation and the role of hepatic stellate cells.Semin Liver Dis2001https://conductscience.org/library/papers/11586466PubMed
1025644077Role of microRNAs -29b-2, -155, -197 and -205 as diagnostic biomarkers in serum of breast cancer females.Gene2015https://conductscience.org/library/papers/25644077PubMed
119500469Reduced angiogenesis and tumor progression in gelatinase A-deficient mice.Cancer Res1998https://conductscience.org/library/papers/9500469PubMed
1230849371VEGF in Signaling and Disease: Beyond Discovery and Development.Cell2019https://conductscience.org/library/papers/30849371PubMed
1317957028Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5.Blood2008https://conductscience.org/library/papers/17957028PubMed
1421793034MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression.Hepatology2011https://conductscience.org/library/papers/21793034PubMed
1521987025Serum microRNAs are promising novel biomarkers for diffuse large B cell lymphoma.Ann Hematol2012https://conductscience.org/library/papers/21987025PubMed
1634470658The HIF1α-PDGFD-PDGFRα axis controls glioblastoma growth at normoxia/mild-hypoxia and confers sensitivity to targeted therapy by echinomycin.J Exp Clin Cancer Res2021https://conductscience.org/library/papers/34470658PubMed
1728368401circRNA_100290 plays a role in oral cancer by functioning as a sponge of the miR-29 family.Oncogene2017https://conductscience.org/library/papers/28368401PubMed
1837062273Downregulation of miR-210-3p Attenuates High Glucose-Induced Angiogenesis of Vascular Endothelial Cells via Targeting FGFRL1.Ophthalmic Res2023https://conductscience.org/library/papers/37062273PubMed
1921376230Hallmarks of cancer: the next generation.Cell2011https://conductscience.org/library/papers/21376230PubMed
2024429633The multilayered complexity of ceRNA crosstalk and competition.Nature2014https://conductscience.org/library/papers/24429633PubMed

See all 115 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
42051962Comparative analysis of DNA methyltransferase 3 alpha and miR-29b expression in eutopic and ectopic endometrial tissues from endometriosis patients compared to healthy controls: A case-control study.Int J Reprod Biomed2026https://conductscience.org/library/papers/42051962PubMed
41868801miR-3921 functions as a tumor suppressor and negatively regulates RIPK1 in gastric cancer.PeerJ2026https://conductscience.org/library/papers/41868801PubMed
41226828MicroRNAs as Emerging Therapeutic Targets Modulating the Tumor Microenvironment in Head and Neck Squamous Cell Carcinoma.Int J Mol Sci2025https://conductscience.org/library/papers/41226828PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
MMP24313PubTator's text mininghttps://conductscience.org/library/genes/4313NCBI Gene
VEGFA7422PubTator's text mininghttps://conductscience.org/library/genes/7422NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40189720

GET https://conductscience.org/api/papers/v1/40189720/references?page=2